Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Wichmann

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Hemasphere|October 16, 2023
CSF3R T618I Collaborates With RUNX1-RUNX1T1 to Expand Hematopoietic Progenitors and Sensitizes to GLI InhibitionAnja S Swoboda, Vanessa C Arfelli, Anna Danese, et al.
Journal of Hematology & Oncology|March 21, 2021
Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemiaHélène Jakobczyk, Lydie Debaize, Benoit Soubise, et al.
The New England Journal of Medicine|March 4, 2026
Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid SyndromeAdrian Gottschlich, Veit Bücklein, Karim El-Marouk, et al.
Cancer Immunology, Immunotherapy : CII|May 22, 2025
Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapyAnna Reischer, Alexandra Leutbecher, Björn Hiller, et al.
Frontiers in Immunology|November 17, 2022
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophagesTobias Zeller, Sebastian Lutz, Ira A Münnich, et al.
Molecular Cancer|July 8, 2023
Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivoEhsan Bahrami, Jan Philipp Schmid, Vindi Jurinovic, et al.
Hemasphere|June 21, 2024
The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300-dependent stemness programAlexandre Fagnan, Zakia Aid, Marie Baille, et al.
Haematologica|April 21, 2018
GFI1 is required for <i>RUNX1/ETO</i> positive acute myeloid leukemiaAnna E Marneth, Lacramioara Botezatu, Judith M Hönes, et al.
Blood|January 22, 2025
Aging platelets shift their hemostatic properties to inflammatory functionsAfra Anjum, Magdalena Mader, Shaan Mahameed, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2024
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytesRoland Windisch, Sarah Soliman, Adrian Hoffmann, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Hemasphere|October 16, 2023
CSF3R T618I Collaborates With RUNX1-RUNX1T1 to Expand Hematopoietic Progenitors and Sensitizes to GLI InhibitionAnja S Swoboda, Vanessa C Arfelli, Anna Danese, et al.
Journal of Hematology & Oncology|March 21, 2021
Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemiaHélène Jakobczyk, Lydie Debaize, Benoit Soubise, et al.
The New England Journal of Medicine|March 4, 2026
Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid SyndromeAdrian Gottschlich, Veit Bücklein, Karim El-Marouk, et al.
Cancer Immunology, Immunotherapy : CII|May 22, 2025
Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapyAnna Reischer, Alexandra Leutbecher, Björn Hiller, et al.
Frontiers in Immunology|November 17, 2022
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophagesTobias Zeller, Sebastian Lutz, Ira A Münnich, et al.
Molecular Cancer|July 8, 2023
Combined proteomics and CRISPR‒Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivoEhsan Bahrami, Jan Philipp Schmid, Vindi Jurinovic, et al.
Hemasphere|June 21, 2024
The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300-dependent stemness programAlexandre Fagnan, Zakia Aid, Marie Baille, et al.
Haematologica|April 21, 2018
GFI1 is required for <i>RUNX1/ETO</i> positive acute myeloid leukemiaAnna E Marneth, Lacramioara Botezatu, Judith M Hönes, et al.
Blood|January 22, 2025
Aging platelets shift their hemostatic properties to inflammatory functionsAfra Anjum, Magdalena Mader, Shaan Mahameed, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2024
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytesRoland Windisch, Sarah Soliman, Adrian Hoffmann, et al.
Pageof 6